New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Investigational drugs block bone loss in mice receiving chemotherapy

Investigational drugs block bone loss in mice receiving chemotherapy

byWashington University School of MedicineRed and green lines represent new bone in this image of a normal mouse bone. Exposure to chemotherapy and radiation during cancer treatment leads to bon
Breakthroughs December 22,2023
Investigational drugs block bone loss in mice receiving chemotherapy

Investigational drugs block bone loss in mice receiving chemotherapy

byWashington University School of MedicineRed and green lines represent new bone in this image of a normal mouse bone. Exposure to chemotherapy and radiation during cancer treatment leads to bon
Breakthroughs December 22,2023
Cancer mortality continues steady decline, driven by progress against lung cancer

Cancer mortality continues steady decline, driven by progress against lung cancer

byAmerican Cancer SocietyTrends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population Credit: American Cancer SocietyTh
Oncology December 22,2023
Cancer mortality continues steady decline, driven by progress against lung cancer

Cancer mortality continues steady decline, driven by progress against lung cancer

byAmerican Cancer SocietyTrends in Overall Cancer Mortality Rates by Sex, United States, 1930 to 2017. Rates are age adjusted to the 2000 US standard population Credit: American Cancer SocietyTh
Oncology December 22,2023
Incidence of early-onset gastric cancer increasing in the U.S.

Incidence of early-onset gastric cancer increasing in the U.S.

(HealthDay)—The incidence of early-onset gastric cancer has been increasing in the United States, and it seems to be distinct clinically and genetically from late-onset gastric cancer, according to a
Oncology December 22,2023
Incidence of early-onset gastric cancer increasing in the U.S.

Incidence of early-onset gastric cancer increasing in the U.S.

(HealthDay)—The incidence of early-onset gastric cancer has been increasing in the United States, and it seems to be distinct clinically and genetically from late-onset gastric cancer, according to a
Oncology December 22,2023
Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

byNYU Langone HealthMouse pancreatic tumor cells (red) produce the signaling protein IL-1β (green) to support cancer growth by suppressing the immune system. Credit: NYU Grossman School of Medic
Oncology December 22,2023
Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

Pancreatic cancer cells secrete signal that sabotages immune attack on tumors

byNYU Langone HealthMouse pancreatic tumor cells (red) produce the signaling protein IL-1β (green) to support cancer growth by suppressing the immune system. Credit: NYU Grossman School of Medic
Oncology December 22,2023
Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

byMcGill UniversityCancer cell during cell division. Credit: National Institutes of HealthIt is known that the tumor microenvironment plays an important role in the progression of cancer. But co
Oncology December 22,2023
Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

Estrogen may facilitate the growth of liver metastases in non-sex-specific cancers

byMcGill UniversityCancer cell during cell division. Credit: National Institutes of HealthIt is known that the tumor microenvironment plays an important role in the progression of cancer. But co
Oncology December 22,2023
Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

byThe Spanish National Cancer Research CentreSection of a mouse invasive mesothelioma tumour. Credit: CNIOExposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggr
Oncology December 22,2023
Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

byThe Spanish National Cancer Research CentreSection of a mouse invasive mesothelioma tumour. Credit: CNIOExposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggr
Oncology December 22,2023
Study shows lactate may prompt cancer formation

Study shows lactate may prompt cancer formation

byCU Anschutz Medical CampusCancer cell during cell division. Credit: National Institutes of HealthA byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutate
Oncology December 22,2023
Study shows lactate may prompt cancer formation

Study shows lactate may prompt cancer formation

byCU Anschutz Medical CampusCancer cell during cell division. Credit: National Institutes of HealthA byproduct of glucose called lactate, used by every cell in the body, may also prompt a mutate
Oncology December 22,2023
Combining neurologic and blood pressure drugs reduces breast tumor development in mice

Combining neurologic and blood pressure drugs reduces breast tumor development in mice

byGeorgetown University Medical CenterCancer cell during cell division. Credit: National Institutes of HealthAdding a medication used to treat epilepsy, bipolar disorder and migraines to a blood
Oncology December 22,2023
Combining neurologic and blood pressure drugs reduces breast tumor development in mice

Combining neurologic and blood pressure drugs reduces breast tumor development in mice

byGeorgetown University Medical CenterCancer cell during cell division. Credit: National Institutes of HealthAdding a medication used to treat epilepsy, bipolar disorder and migraines to a blood
Oncology December 22,2023
Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

byUniversity of Texas M. D. Anderson Cancer CenterCancer cell during cell division. Credit: National Institutes of HealthA study at The University of Texas MD Anderson Cancer Center demonstrated
Oncology December 22,2023
Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

byUniversity of Texas M. D. Anderson Cancer CenterCancer cell during cell division. Credit: National Institutes of HealthA study at The University of Texas MD Anderson Cancer Center demonstrated
Oncology December 22,2023
Study finds novel molecular therapeutic target for colon cancer

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col
Oncology December 22,2023
Study finds novel molecular therapeutic target for colon cancer

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col
Oncology December 22,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com